nodes	percent_of_prediction	percent_of_DWPC	metapath
Mepivacaine—Cranial nerve paralysis—Methotrexate—psoriatic arthritis	0.0622	0.0622	CcSEcCtD
Mepivacaine—Meningism—Methotrexate—psoriatic arthritis	0.0414	0.0414	CcSEcCtD
Mepivacaine—Meningitis—Prednisolone—psoriatic arthritis	0.0305	0.0305	CcSEcCtD
Mepivacaine—Meningitis—Triamcinolone—psoriatic arthritis	0.028	0.028	CcSEcCtD
Mepivacaine—Meningitis—Methylprednisolone—psoriatic arthritis	0.028	0.028	CcSEcCtD
Mepivacaine—Meningitis—Dexamethasone—psoriatic arthritis	0.0254	0.0254	CcSEcCtD
Mepivacaine—Meningitis—Betamethasone—psoriatic arthritis	0.0254	0.0254	CcSEcCtD
Mepivacaine—Meningitis—Prednisone—psoriatic arthritis	0.0221	0.0221	CcSEcCtD
Mepivacaine—Sneezing—Triamcinolone—psoriatic arthritis	0.0196	0.0196	CcSEcCtD
Mepivacaine—Angioedema—Auranofin—psoriatic arthritis	0.0148	0.0148	CcSEcCtD
Mepivacaine—Urticaria—Auranofin—psoriatic arthritis	0.0105	0.0105	CcSEcCtD
Mepivacaine—Paralysis—Methotrexate—psoriatic arthritis	0.0103	0.0103	CcSEcCtD
Mepivacaine—Pruritus—Auranofin—psoriatic arthritis	0.00935	0.00935	CcSEcCtD
Mepivacaine—Anaphylactoid reaction—Prednisolone—psoriatic arthritis	0.00886	0.00886	CcSEcCtD
Mepivacaine—Apnoea—Methotrexate—psoriatic arthritis	0.00846	0.00846	CcSEcCtD
Mepivacaine—Vomiting—Auranofin—psoriatic arthritis	0.0084	0.0084	CcSEcCtD
Mepivacaine—Cardiac arrest—Prednisolone—psoriatic arthritis	0.00815	0.00815	CcSEcCtD
Mepivacaine—Anaphylactoid reaction—Triamcinolone—psoriatic arthritis	0.00815	0.00815	CcSEcCtD
Mepivacaine—Anaphylactoid reaction—Methylprednisolone—psoriatic arthritis	0.00813	0.00813	CcSEcCtD
Mepivacaine—Nausea—Auranofin—psoriatic arthritis	0.00785	0.00785	CcSEcCtD
Mepivacaine—Cardiac arrest—Triamcinolone—psoriatic arthritis	0.0075	0.0075	CcSEcCtD
Mepivacaine—Cardiac arrest—Methylprednisolone—psoriatic arthritis	0.00748	0.00748	CcSEcCtD
Mepivacaine—Anaphylactoid reaction—Betamethasone—psoriatic arthritis	0.00739	0.00739	CcSEcCtD
Mepivacaine—Anaphylactoid reaction—Dexamethasone—psoriatic arthritis	0.00739	0.00739	CcSEcCtD
Mepivacaine—Sweating increased—Prednisolone—psoriatic arthritis	0.00722	0.00722	CcSEcCtD
Mepivacaine—Cardiac arrest—Betamethasone—psoriatic arthritis	0.0068	0.0068	CcSEcCtD
Mepivacaine—Cardiac arrest—Dexamethasone—psoriatic arthritis	0.0068	0.0068	CcSEcCtD
Mepivacaine—Sweating increased—Triamcinolone—psoriatic arthritis	0.00664	0.00664	CcSEcCtD
Mepivacaine—Sweating increased—Methylprednisolone—psoriatic arthritis	0.00662	0.00662	CcSEcCtD
Mepivacaine—Bradycardia—Prednisolone—psoriatic arthritis	0.00604	0.00604	CcSEcCtD
Mepivacaine—Sweating increased—Betamethasone—psoriatic arthritis	0.00602	0.00602	CcSEcCtD
Mepivacaine—Sweating increased—Dexamethasone—psoriatic arthritis	0.00602	0.00602	CcSEcCtD
Mepivacaine—Cardiac arrest—Prednisone—psoriatic arthritis	0.00593	0.00593	CcSEcCtD
Mepivacaine—Sweating—Methylprednisolone—psoriatic arthritis	0.00581	0.00581	CcSEcCtD
Mepivacaine—Bradycardia—Triamcinolone—psoriatic arthritis	0.00555	0.00555	CcSEcCtD
Mepivacaine—Bradycardia—Methylprednisolone—psoriatic arthritis	0.00554	0.00554	CcSEcCtD
Mepivacaine—Anaphylactoid reaction—Methotrexate—psoriatic arthritis	0.00538	0.00538	CcSEcCtD
Mepivacaine—Sweating increased—Prednisone—psoriatic arthritis	0.00525	0.00525	CcSEcCtD
Mepivacaine—Erythema—Prednisolone—psoriatic arthritis	0.00516	0.00516	CcSEcCtD
Mepivacaine—Bradycardia—Dexamethasone—psoriatic arthritis	0.00504	0.00504	CcSEcCtD
Mepivacaine—Bradycardia—Betamethasone—psoriatic arthritis	0.00504	0.00504	CcSEcCtD
Mepivacaine—Vision blurred—Prednisolone—psoriatic arthritis	0.00487	0.00487	CcSEcCtD
Mepivacaine—Erythema—Triamcinolone—psoriatic arthritis	0.00475	0.00475	CcSEcCtD
Mepivacaine—Erythema—Methylprednisolone—psoriatic arthritis	0.00474	0.00474	CcSEcCtD
Mepivacaine—Angioedema—Prednisolone—psoriatic arthritis	0.00472	0.00472	CcSEcCtD
Mepivacaine—Syncope—Prednisolone—psoriatic arthritis	0.00463	0.00463	CcSEcCtD
Mepivacaine—Back pain—Triamcinolone—psoriatic arthritis	0.00459	0.00459	CcSEcCtD
Mepivacaine—Loss of consciousness—Prednisolone—psoriatic arthritis	0.00454	0.00454	CcSEcCtD
Mepivacaine—Convulsion—Prednisolone—psoriatic arthritis	0.00447	0.00447	CcSEcCtD
Mepivacaine—Hypertension—Prednisolone—psoriatic arthritis	0.00446	0.00446	CcSEcCtD
Mepivacaine—Bradycardia—Prednisone—psoriatic arthritis	0.00439	0.00439	CcSEcCtD
Mepivacaine—Angioedema—Triamcinolone—psoriatic arthritis	0.00434	0.00434	CcSEcCtD
Mepivacaine—Angioedema—Methylprednisolone—psoriatic arthritis	0.00433	0.00433	CcSEcCtD
Mepivacaine—Erythema—Dexamethasone—psoriatic arthritis	0.00431	0.00431	CcSEcCtD
Mepivacaine—Erythema—Betamethasone—psoriatic arthritis	0.00431	0.00431	CcSEcCtD
Mepivacaine—Syncope—Triamcinolone—psoriatic arthritis	0.00426	0.00426	CcSEcCtD
Mepivacaine—Syncope—Methylprednisolone—psoriatic arthritis	0.00425	0.00425	CcSEcCtD
Mepivacaine—Oedema—Prednisolone—psoriatic arthritis	0.00421	0.00421	CcSEcCtD
Mepivacaine—Anaphylactic shock—Prednisolone—psoriatic arthritis	0.00421	0.00421	CcSEcCtD
Mepivacaine—Loss of consciousness—Triamcinolone—psoriatic arthritis	0.00417	0.00417	CcSEcCtD
Mepivacaine—Loss of consciousness—Methylprednisolone—psoriatic arthritis	0.00416	0.00416	CcSEcCtD
Mepivacaine—Shock—Prednisolone—psoriatic arthritis	0.00415	0.00415	CcSEcCtD
Mepivacaine—Convulsion—Triamcinolone—psoriatic arthritis	0.00411	0.00411	CcSEcCtD
Mepivacaine—Tachycardia—Prednisolone—psoriatic arthritis	0.00411	0.00411	CcSEcCtD
Mepivacaine—Convulsion—Methylprednisolone—psoriatic arthritis	0.00411	0.00411	CcSEcCtD
Mepivacaine—Hypertension—Triamcinolone—psoriatic arthritis	0.0041	0.0041	CcSEcCtD
Mepivacaine—Hypertension—Methylprednisolone—psoriatic arthritis	0.00409	0.00409	CcSEcCtD
Mepivacaine—Hyperhidrosis—Prednisolone—psoriatic arthritis	0.00407	0.00407	CcSEcCtD
Mepivacaine—Anxiety—Methylprednisolone—psoriatic arthritis	0.00402	0.00402	CcSEcCtD
Mepivacaine—Drowsiness—Methotrexate—psoriatic arthritis	0.00401	0.00401	CcSEcCtD
Mepivacaine—Angioedema—Dexamethasone—psoriatic arthritis	0.00394	0.00394	CcSEcCtD
Mepivacaine—Angioedema—Betamethasone—psoriatic arthritis	0.00394	0.00394	CcSEcCtD
Mepivacaine—Anaphylactic shock—Triamcinolone—psoriatic arthritis	0.00388	0.00388	CcSEcCtD
Mepivacaine—Oedema—Triamcinolone—psoriatic arthritis	0.00388	0.00388	CcSEcCtD
Mepivacaine—Anaphylactic shock—Methylprednisolone—psoriatic arthritis	0.00387	0.00387	CcSEcCtD
Mepivacaine—Syncope—Betamethasone—psoriatic arthritis	0.00386	0.00386	CcSEcCtD
Mepivacaine—Syncope—Dexamethasone—psoriatic arthritis	0.00386	0.00386	CcSEcCtD
Mepivacaine—Sweating—Methotrexate—psoriatic arthritis	0.00385	0.00385	CcSEcCtD
Mepivacaine—Shock—Triamcinolone—psoriatic arthritis	0.00381	0.00381	CcSEcCtD
Mepivacaine—Shock—Methylprednisolone—psoriatic arthritis	0.0038	0.0038	CcSEcCtD
Mepivacaine—Loss of consciousness—Betamethasone—psoriatic arthritis	0.00379	0.00379	CcSEcCtD
Mepivacaine—Loss of consciousness—Dexamethasone—psoriatic arthritis	0.00379	0.00379	CcSEcCtD
Mepivacaine—Paraesthesia—Prednisolone—psoriatic arthritis	0.00378	0.00378	CcSEcCtD
Mepivacaine—Tachycardia—Triamcinolone—psoriatic arthritis	0.00378	0.00378	CcSEcCtD
Mepivacaine—Tachycardia—Methylprednisolone—psoriatic arthritis	0.00377	0.00377	CcSEcCtD
Mepivacaine—Erythema—Prednisone—psoriatic arthritis	0.00375	0.00375	CcSEcCtD
Mepivacaine—Hyperhidrosis—Triamcinolone—psoriatic arthritis	0.00375	0.00375	CcSEcCtD
Mepivacaine—Hyperhidrosis—Methylprednisolone—psoriatic arthritis	0.00374	0.00374	CcSEcCtD
Mepivacaine—Convulsion—Dexamethasone—psoriatic arthritis	0.00373	0.00373	CcSEcCtD
Mepivacaine—Convulsion—Betamethasone—psoriatic arthritis	0.00373	0.00373	CcSEcCtD
Mepivacaine—Hypertension—Dexamethasone—psoriatic arthritis	0.00372	0.00372	CcSEcCtD
Mepivacaine—Hypertension—Betamethasone—psoriatic arthritis	0.00372	0.00372	CcSEcCtD
Mepivacaine—Anxiety—Dexamethasone—psoriatic arthritis	0.00366	0.00366	CcSEcCtD
Mepivacaine—Anxiety—Betamethasone—psoriatic arthritis	0.00366	0.00366	CcSEcCtD
Mepivacaine—Hypotension—Methylprednisolone—psoriatic arthritis	0.00361	0.00361	CcSEcCtD
Mepivacaine—Vision blurred—Prednisone—psoriatic arthritis	0.00354	0.00354	CcSEcCtD
Mepivacaine—Anaphylactic shock—Dexamethasone—psoriatic arthritis	0.00352	0.00352	CcSEcCtD
Mepivacaine—Anaphylactic shock—Betamethasone—psoriatic arthritis	0.00352	0.00352	CcSEcCtD
Mepivacaine—Oedema—Betamethasone—psoriatic arthritis	0.00352	0.00352	CcSEcCtD
Mepivacaine—Oedema—Dexamethasone—psoriatic arthritis	0.00352	0.00352	CcSEcCtD
Mepivacaine—Paraesthesia—Triamcinolone—psoriatic arthritis	0.00348	0.00348	CcSEcCtD
Mepivacaine—Paraesthesia—Methylprednisolone—psoriatic arthritis	0.00347	0.00347	CcSEcCtD
Mepivacaine—Shock—Dexamethasone—psoriatic arthritis	0.00346	0.00346	CcSEcCtD
Mepivacaine—Shock—Betamethasone—psoriatic arthritis	0.00346	0.00346	CcSEcCtD
Mepivacaine—Agitation—Prednisone—psoriatic arthritis	0.00345	0.00345	CcSEcCtD
Mepivacaine—Tachycardia—Betamethasone—psoriatic arthritis	0.00343	0.00343	CcSEcCtD
Mepivacaine—Tachycardia—Dexamethasone—psoriatic arthritis	0.00343	0.00343	CcSEcCtD
Mepivacaine—Angioedema—Prednisone—psoriatic arthritis	0.00343	0.00343	CcSEcCtD
Mepivacaine—Hyperhidrosis—Dexamethasone—psoriatic arthritis	0.0034	0.0034	CcSEcCtD
Mepivacaine—Hyperhidrosis—Betamethasone—psoriatic arthritis	0.0034	0.0034	CcSEcCtD
Mepivacaine—Syncope—Prednisone—psoriatic arthritis	0.00337	0.00337	CcSEcCtD
Mepivacaine—Tinnitus—Methotrexate—psoriatic arthritis	0.00336	0.00336	CcSEcCtD
Mepivacaine—Urticaria—Prednisolone—psoriatic arthritis	0.00335	0.00335	CcSEcCtD
Mepivacaine—Loss of consciousness—Prednisone—psoriatic arthritis	0.0033	0.0033	CcSEcCtD
Mepivacaine—Hypotension—Dexamethasone—psoriatic arthritis	0.00329	0.00329	CcSEcCtD
Mepivacaine—Hypotension—Betamethasone—psoriatic arthritis	0.00329	0.00329	CcSEcCtD
Mepivacaine—Convulsion—Prednisone—psoriatic arthritis	0.00325	0.00325	CcSEcCtD
Mepivacaine—Hypertension—Prednisone—psoriatic arthritis	0.00324	0.00324	CcSEcCtD
Mepivacaine—Chills—Methotrexate—psoriatic arthritis	0.00323	0.00323	CcSEcCtD
Mepivacaine—Anxiety—Prednisone—psoriatic arthritis	0.00318	0.00318	CcSEcCtD
Mepivacaine—Paraesthesia—Betamethasone—psoriatic arthritis	0.00316	0.00316	CcSEcCtD
Mepivacaine—Paraesthesia—Dexamethasone—psoriatic arthritis	0.00316	0.00316	CcSEcCtD
Mepivacaine—Erythema—Methotrexate—psoriatic arthritis	0.00314	0.00314	CcSEcCtD
Mepivacaine—Hypersensitivity—Prednisolone—psoriatic arthritis	0.00311	0.00311	CcSEcCtD
Mepivacaine—Urticaria—Triamcinolone—psoriatic arthritis	0.00308	0.00308	CcSEcCtD
Mepivacaine—Urticaria—Methylprednisolone—psoriatic arthritis	0.00307	0.00307	CcSEcCtD
Mepivacaine—Body temperature increased—Triamcinolone—psoriatic arthritis	0.00306	0.00306	CcSEcCtD
Mepivacaine—Anaphylactic shock—Prednisone—psoriatic arthritis	0.00306	0.00306	CcSEcCtD
Mepivacaine—Oedema—Prednisone—psoriatic arthritis	0.00306	0.00306	CcSEcCtD
Mepivacaine—Back pain—Methotrexate—psoriatic arthritis	0.00303	0.00303	CcSEcCtD
Mepivacaine—Shock—Prednisone—psoriatic arthritis	0.00301	0.00301	CcSEcCtD
Mepivacaine—Tachycardia—Prednisone—psoriatic arthritis	0.00299	0.00299	CcSEcCtD
Mepivacaine—Hyperhidrosis—Prednisone—psoriatic arthritis	0.00296	0.00296	CcSEcCtD
Mepivacaine—Vision blurred—Methotrexate—psoriatic arthritis	0.00296	0.00296	CcSEcCtD
Mepivacaine—Hypersensitivity—Triamcinolone—psoriatic arthritis	0.00286	0.00286	CcSEcCtD
Mepivacaine—Hypersensitivity—Methylprednisolone—psoriatic arthritis	0.00285	0.00285	CcSEcCtD
Mepivacaine—Urticaria—Dexamethasone—psoriatic arthritis	0.00279	0.00279	CcSEcCtD
Mepivacaine—Urticaria—Betamethasone—psoriatic arthritis	0.00279	0.00279	CcSEcCtD
Mepivacaine—Dizziness—Prednisolone—psoriatic arthritis	0.00279	0.00279	CcSEcCtD
Mepivacaine—Asthenia—Triamcinolone—psoriatic arthritis	0.00278	0.00278	CcSEcCtD
Mepivacaine—Body temperature increased—Betamethasone—psoriatic arthritis	0.00278	0.00278	CcSEcCtD
Mepivacaine—Body temperature increased—Dexamethasone—psoriatic arthritis	0.00278	0.00278	CcSEcCtD
Mepivacaine—Asthenia—Methylprednisolone—psoriatic arthritis	0.00277	0.00277	CcSEcCtD
Mepivacaine—Paraesthesia—Prednisone—psoriatic arthritis	0.00275	0.00275	CcSEcCtD
Mepivacaine—Pruritus—Triamcinolone—psoriatic arthritis	0.00274	0.00274	CcSEcCtD
Mepivacaine—Pruritus—Methylprednisolone—psoriatic arthritis	0.00274	0.00274	CcSEcCtD
Mepivacaine—Convulsion—Methotrexate—psoriatic arthritis	0.00272	0.00272	CcSEcCtD
Mepivacaine—Headache—Prednisolone—psoriatic arthritis	0.00264	0.00264	CcSEcCtD
Mepivacaine—Dizziness—Triamcinolone—psoriatic arthritis	0.00256	0.00256	CcSEcCtD
Mepivacaine—Anaphylactic shock—Methotrexate—psoriatic arthritis	0.00256	0.00256	CcSEcCtD
Mepivacaine—Dizziness—Methylprednisolone—psoriatic arthritis	0.00256	0.00256	CcSEcCtD
Mepivacaine—Asthenia—Betamethasone—psoriatic arthritis	0.00252	0.00252	CcSEcCtD
Mepivacaine—Asthenia—Dexamethasone—psoriatic arthritis	0.00252	0.00252	CcSEcCtD
Mepivacaine—Nausea—Prednisolone—psoriatic arthritis	0.0025	0.0025	CcSEcCtD
Mepivacaine—Pruritus—Betamethasone—psoriatic arthritis	0.00249	0.00249	CcSEcCtD
Mepivacaine—Pruritus—Dexamethasone—psoriatic arthritis	0.00249	0.00249	CcSEcCtD
Mepivacaine—Hyperhidrosis—Methotrexate—psoriatic arthritis	0.00247	0.00247	CcSEcCtD
Mepivacaine—Vomiting—Triamcinolone—psoriatic arthritis	0.00246	0.00246	CcSEcCtD
Mepivacaine—Vomiting—Methylprednisolone—psoriatic arthritis	0.00246	0.00246	CcSEcCtD
Mepivacaine—Urticaria—Prednisone—psoriatic arthritis	0.00243	0.00243	CcSEcCtD
Mepivacaine—Headache—Triamcinolone—psoriatic arthritis	0.00243	0.00243	CcSEcCtD
Mepivacaine—Headache—Methylprednisolone—psoriatic arthritis	0.00242	0.00242	CcSEcCtD
Mepivacaine—Body temperature increased—Prednisone—psoriatic arthritis	0.00242	0.00242	CcSEcCtD
Mepivacaine—Hypotension—Methotrexate—psoriatic arthritis	0.00239	0.00239	CcSEcCtD
Mepivacaine—Dizziness—Dexamethasone—psoriatic arthritis	0.00233	0.00233	CcSEcCtD
Mepivacaine—Dizziness—Betamethasone—psoriatic arthritis	0.00233	0.00233	CcSEcCtD
Mepivacaine—Nausea—Triamcinolone—psoriatic arthritis	0.0023	0.0023	CcSEcCtD
Mepivacaine—Paraesthesia—Methotrexate—psoriatic arthritis	0.0023	0.0023	CcSEcCtD
Mepivacaine—Nausea—Methylprednisolone—psoriatic arthritis	0.0023	0.0023	CcSEcCtD
Mepivacaine—Somnolence—Methotrexate—psoriatic arthritis	0.00228	0.00228	CcSEcCtD
Mepivacaine—Hypersensitivity—Prednisone—psoriatic arthritis	0.00226	0.00226	CcSEcCtD
Mepivacaine—Vomiting—Betamethasone—psoriatic arthritis	0.00224	0.00224	CcSEcCtD
Mepivacaine—Vomiting—Dexamethasone—psoriatic arthritis	0.00224	0.00224	CcSEcCtD
Mepivacaine—Headache—Betamethasone—psoriatic arthritis	0.0022	0.0022	CcSEcCtD
Mepivacaine—Headache—Dexamethasone—psoriatic arthritis	0.0022	0.0022	CcSEcCtD
Mepivacaine—Asthenia—Prednisone—psoriatic arthritis	0.0022	0.0022	CcSEcCtD
Mepivacaine—Pruritus—Prednisone—psoriatic arthritis	0.00217	0.00217	CcSEcCtD
Mepivacaine—Nausea—Dexamethasone—psoriatic arthritis	0.00209	0.00209	CcSEcCtD
Mepivacaine—Nausea—Betamethasone—psoriatic arthritis	0.00209	0.00209	CcSEcCtD
Mepivacaine—Urticaria—Methotrexate—psoriatic arthritis	0.00203	0.00203	CcSEcCtD
Mepivacaine—Dizziness—Prednisone—psoriatic arthritis	0.00203	0.00203	CcSEcCtD
Mepivacaine—Body temperature increased—Methotrexate—psoriatic arthritis	0.00202	0.00202	CcSEcCtD
Mepivacaine—Vomiting—Prednisone—psoriatic arthritis	0.00195	0.00195	CcSEcCtD
Mepivacaine—Headache—Prednisone—psoriatic arthritis	0.00192	0.00192	CcSEcCtD
Mepivacaine—Hypersensitivity—Methotrexate—psoriatic arthritis	0.00189	0.00189	CcSEcCtD
Mepivacaine—Asthenia—Methotrexate—psoriatic arthritis	0.00184	0.00184	CcSEcCtD
Mepivacaine—Nausea—Prednisone—psoriatic arthritis	0.00182	0.00182	CcSEcCtD
Mepivacaine—Pruritus—Methotrexate—psoriatic arthritis	0.00181	0.00181	CcSEcCtD
Mepivacaine—Dizziness—Methotrexate—psoriatic arthritis	0.00169	0.00169	CcSEcCtD
Mepivacaine—Vomiting—Methotrexate—psoriatic arthritis	0.00163	0.00163	CcSEcCtD
Mepivacaine—Headache—Methotrexate—psoriatic arthritis	0.0016	0.0016	CcSEcCtD
Mepivacaine—Nausea—Methotrexate—psoriatic arthritis	0.00152	0.00152	CcSEcCtD
